Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanlei Ma

Showing results (21-30 of 129) with videos related to

Pageof 13
Sort By:
Theranostics|January 18, 2021
N<sup>6</sup>-methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future directionJinming Li, Lei Liang, Yongzhi Yang, et al.
Trends in Microbiology|July 2, 2023
Decoding the microbiome: advances in genetic manipulation for gut bacteriaZiying Chen, Wenbing Jin, Alex Hoover, et al.
Molecular Biology Reports|February 22, 2012
Metabolomics in the fields of oncology: a review of recent researchYanlei Ma, Peng Zhang, Yongzhi Yang, et al.
International Journal of Cancer|July 22, 2014
Hippo-YAP signaling pathway: A new paradigm for cancer therapyYanlei Ma, Yongzhi Yang, Feng Wang, et al.
Cancer Letters|February 12, 2021
Long non-coding RNAs in colorectal cancer: Novel oncogenic mechanisms and promising clinical applicationsYufei Yang, Xuebing Yan, Xinxiang Li, et al.
Journal of Medical Virology|February 11, 2023
Dysbiosis of the stool DNA and RNA virome in Crohn's diseaseCheng Kong, Guang Liu, Matthew F Kalady, et al.
Breast Cancer Research and Treatment|June 5, 2010
Lack of association between HER2 codon 655 polymorphism and breast cancer susceptibility: meta-analysis of 22 studies involving 19,341 subjectsYanlei Ma, Jianjun Yang, Peng Zhang, et al.
Plos One|May 19, 2012
Cyclin D1 G870A polymorphism contributes to colorectal cancer susceptibility: evidence from a systematic review of 22 case-control studiesYongzhi Yang, Feng Wang, Chenzhang Shi, et al.
RSC Advances|July 3, 2026
Cyclomulberrin from <i>Morus alba</i> L. exerts antithrombotic effects by modulating platelet activation: an integrated network pharmacology and <i>in vitro</i> studyYanqiong Guo, Rongrong He, Jing Peng, et al.
International Journal of Colorectal Disease|May 18, 2018
Real-world study of a novel prognostic scoring system: for a more precise prognostication and better clinical treatment guidance in stages II and III colon cancerQi Liu, Yanlei Ma, Dakui Luo, et al.
Pageof 13

Showing results (21-30 of 129) with videos related to

Sort By:
Pageof 13
Theranostics|January 18, 2021
N<sup>6</sup>-methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future directionJinming Li, Lei Liang, Yongzhi Yang, et al.
Trends in Microbiology|July 2, 2023
Decoding the microbiome: advances in genetic manipulation for gut bacteriaZiying Chen, Wenbing Jin, Alex Hoover, et al.
Molecular Biology Reports|February 22, 2012
Metabolomics in the fields of oncology: a review of recent researchYanlei Ma, Peng Zhang, Yongzhi Yang, et al.
International Journal of Cancer|July 22, 2014
Hippo-YAP signaling pathway: A new paradigm for cancer therapyYanlei Ma, Yongzhi Yang, Feng Wang, et al.
Cancer Letters|February 12, 2021
Long non-coding RNAs in colorectal cancer: Novel oncogenic mechanisms and promising clinical applicationsYufei Yang, Xuebing Yan, Xinxiang Li, et al.
Journal of Medical Virology|February 11, 2023
Dysbiosis of the stool DNA and RNA virome in Crohn's diseaseCheng Kong, Guang Liu, Matthew F Kalady, et al.
Breast Cancer Research and Treatment|June 5, 2010
Lack of association between HER2 codon 655 polymorphism and breast cancer susceptibility: meta-analysis of 22 studies involving 19,341 subjectsYanlei Ma, Jianjun Yang, Peng Zhang, et al.
Plos One|May 19, 2012
Cyclin D1 G870A polymorphism contributes to colorectal cancer susceptibility: evidence from a systematic review of 22 case-control studiesYongzhi Yang, Feng Wang, Chenzhang Shi, et al.
RSC Advances|July 3, 2026
Cyclomulberrin from <i>Morus alba</i> L. exerts antithrombotic effects by modulating platelet activation: an integrated network pharmacology and <i>in vitro</i> studyYanqiong Guo, Rongrong He, Jing Peng, et al.
International Journal of Colorectal Disease|May 18, 2018
Real-world study of a novel prognostic scoring system: for a more precise prognostication and better clinical treatment guidance in stages II and III colon cancerQi Liu, Yanlei Ma, Dakui Luo, et al.
Pageof 13